{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigoiaulgbhwihncxcwadnkxbpfossjladknbr4s7ebzv56oj4xlpq",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mitic3rzblw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihonqkkm5epkzjhjtkzzg4xq5aip254dosxawy2xgm653vd4vexga"
    },
    "mimeType": "image/jpeg",
    "size": 801785
  },
  "path": "/news/2026-04-glp-agonist-drugs-digestive-side.html",
  "publishedAt": "2026-04-06T10:00:05.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella review draws attention to safety concerns regarding the use of this GLP medication, alongside a mix of potential benefits.",
  "title": "GLP-1 agonist drugs show digestive side effects but may help fight infections"
}